Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страна 1 од 41 резултати
Method for treating ocular hypertension and glaucoma
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
The present invention relates to a method for treating ocular hypertension and glaucoma with reduced side effects, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof, which contains substantially no benzalkonium
Method for treating ocular hypertension and glaucoma
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
The present invention relates to a method for treating ocular hypertension and glaucoma with reduced side effects, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof, which contains substantially no benzalkonium
RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
The present invention relates to the field of interfering RNA compositions for inhibition of expression of hypoxia-inducible factor-1.alpha. (HIF-1.alpha.), the protein encoded by HIF1A mRNA, in ocular angiogenesis, including those cellular changes resulting from the
Preservative system for ophthalmic formulations
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
The present invention relates to improved ophthalmic formulations, particularly to ophthalmic formulations which use an improved preservative system comprising a quaternary ammonium preservative and a stabilizing amount of a nonionic polyoxyethylated octylphenol surfactant for
Compositions and methods for the suppression of carbonic anhydrase activity
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
PRIORITY
This application is a national phase filing of the Patent Cooperation Treaty (PCT) application # PCT/IB2013/050899 titled "COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF CARBONIC ANHYDRASE ACTIVITY" filed on Feb. 3, 2013 Published with WIPO Publication # WO/2013/167994, which further
Use of pyrrolo pyrroles in treatment of ophthalmic diseases
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a method for the treatment of ophthalmic diseases originating from or associated with inflammation.
2. Related Disclosure
Many ophthalmic diseases are ocular disorders which are either caused or associated with painful
Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention relates to the field of ophthalmology. In particular, the present invention relates to the treatment of retinal tissues. More specifically, the present invention discloses compositions and methods of using adenosine uptake inhibitors in the prevention or treatment of retinal
Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
The present invention relates to novel methods for the treatment or prevention of glaucoma, ocular hypertension, and other ophthalmic disorders exhibiting elevated intraocular pressure, as well as ocular disorders characterized by retinal neurodegeneration or edema including
Production method for isoquinoline derivatives and salts thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
The present invention relates to a method for producing an isoquinoline derivative or a salt thereof which is useful for preventing and treating cerebrovascular disorders such as cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral edema, particularly as a
Production method for isoquinoline derivatives and salts thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
This application is a National Stage of PCT/JP11/069,187 filed Aug. 25, 2011 and claims the benefit of JP 2010-189392 filed Aug. 26, 2010.
TECHNICAL FIELD
The present invention relates to a method for producing an isoquinoline derivative or a salt thereof which is useful for preventing and treating
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis, and they regulate angiogenesis in a variety of processes. Undesirable or pathological angiogenesis is associated with diseases including diabetic retinopathy, psoriasis, cancer, rheumatoid
Urea derivatives and uses thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
Urea derivatives and uses thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
Urea derivatives and uses thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
Urea derivatives and uses thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
